gvtcx

TPOXX® Antiviral Treatment (Tecovirimat)

key details

Statuscomplete
Category (CPV) 33651400
Procedurelimited
OCIDocds-h6vhtk-037efd

Award

SupplierValueDateStatus
MERIDIAN MEDICAL TECHNOLOGIES LIMITED · · active

description

The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Nov 2022 Contract award notice (F03) Earlier regulations 031159-2022

more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.